Shift to Cautious Expansion and Lean Operations in Biopharma Industry

This week on "The Top Line," we explore biopharma layoffs in the first quarter of 2024. 

Using data from Fierce Biotech's layoff tracker, Gabrielle Masson and Max Bayer analyze the trends of layoffs in the first quarter of 2024, comparing them to previous years. With a notable number of layoff rounds marking the start of the year, they examine the factors behind this ongoing challenge while also highlighting positive industry developments.

To learn more about the topics in this episode: 

• No reprieve for biopharma layoffs in Q1: Fierce Biotech analysis
• Fierce Biotech Layoff Tracker 2024

See omnystudio.com/listener for privacy information.